Acute plasmablastic leukemia (APL) can develop in multiple myeloma (MM) patients. This rare progression often results in poor outcomes, with limited treatment success and short survival times.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: